• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
Is it necessary to do surgical fixation in metastatic bone disease impending pathologic fracture before Lu-prostate-specific membrane antigen radionuclide therapy?在进行镥-前列腺特异性膜抗原放射性核素治疗之前，对于即将发生病理性骨折的转移性骨病，是否有必要进行手术固定？
World J Nucl Med. 2021 Sep 22;20(4):414-416. doi: 10.4103/wjnm.wjnm_147_20. eCollection 2021 Oct-Dec.
2
Efficacy and Safety of Lu-labeled Prostate-specific Membrane Antigen Radionuclide Treatment in Patients with Diffuse Bone Marrow Involvement: A Multicenter Retrospective Study.Lu 标记前列腺特异性膜抗原放射性核素治疗弥漫性骨髓受累患者的疗效和安全性：一项多中心回顾性研究。
Eur Urol. 2020 Aug;78(2):148-154. doi: 10.1016/j.eururo.2020.05.004. Epub 2020 Jun 10.
3
Early Prostate-Specific Antigen Changes and Clinical Outcome After Lu-PSMA Radionuclide Treatment in Patients with Metastatic Castration-Resistant Prostate Cancer.Lu-PSMA 放射性核素治疗转移性去势抵抗性前列腺癌患者后的早期前列腺特异性抗原变化和临床结局。
J Nucl Med. 2020 Oct;61(10):1476-1483. doi: 10.2967/jnumed.119.240242. Epub 2020 Feb 28.
4
A Retrospective Analysis of the Safety and Activity of Lutetium-177-Prostate-Specific Membrane Antigen Radionuclide Treatment in Older Patients with Metastatic Castration-Resistant Prostate Cancer.镥-177-前列腺特异性膜抗原放射性核素治疗在转移性去势抵抗性前列腺癌老年患者中的安全性和疗效的回顾性分析。
Oncologist. 2020 Sep;25(9):787-792. doi: 10.1634/theoncologist.2020-0100. Epub 2020 Jun 10.
5
[Lu]-PSMA-617 radionuclide treatment in patients with metastatic castration-resistant prostate cancer (LuPSMA trial): a single-centre, single-arm, phase 2 study.[镥]-PSMA-617 放射性核素治疗转移性去势抵抗性前列腺癌患者（LuPSMA 试验）：一项单中心、单臂、2 期研究。
Lancet Oncol. 2018 Jun;19(6):825-833. doi: 10.1016/S1470-2045(18)30198-0. Epub 2018 May 8.
6
Is It Appropriate to Treat Sarcoma Metastases With Intramedullary Nailing?使用髓内钉治疗肉瘤转移灶是否合适？
Clin Orthop Relat Res. 2017 Jan;475(1):212-217. doi: 10.1007/s11999-016-5069-8. Epub 2016 Nov 1.
7
Is Prophylactic Intervention More Cost-effective Than the Treatment of Pathologic Fractures in Metastatic Bone Disease?预防性干预在转移性骨病中是否比病理性骨折治疗更具成本效益？
Clin Orthop Relat Res. 2016 Jul;474(7):1563-70. doi: 10.1007/s11999-016-4739-x. Epub 2016 Mar 28.
8
Phase I trial of docetaxel plus lutetium-177-labeled anti-prostate-specific membrane antigen monoclonal antibody J591 (Lu-J591) for metastatic castration-resistant prostate cancer.多西他赛联合镥-177标记的抗前列腺特异性膜抗原单克隆抗体J591（Lu-J591）用于转移性去势抵抗性前列腺癌的I期试验。
Urol Oncol. 2020 Nov;38(11):848.e9-848.e16. doi: 10.1016/j.urolonc.2020.05.028. Epub 2020 Jun 27.
9
Examining Absorbed Doses of Indigenously Developed Lu-PSMA-617 in Metastatic Castration-Resistant Prostate Cancer Patients at Baseline and During Course of Peptide Receptor Radioligand Therapy.检测基线和肽受体放射性配体治疗过程中转移性去势抵抗性前列腺癌患者中内源性开发的 Lu-PSMA-617 的吸收剂量。
Cancer Biother Radiopharm. 2021 Apr;36(3):292-304. doi: 10.1089/cbr.2020.3640. Epub 2020 May 5.
10
Image-guided Percutaneous Fixation with Internal Cemented Screws of Impending Femoral Neck Pathologic Fractures in Patients with Metastatic Cancer: Safety, Efficacy, and Durability.影像引导下经皮置入带水泥螺钉治疗转移性骨肿瘤股骨颈病理性骨折：安全性、疗效及持久性。
Radiology. 2020 Dec;297(3):721-729. doi: 10.1148/radiol.2020201341. Epub 2020 Oct 6.

本文引用的文献

1
Spine and Non-spine Bone Metastases - Current Controversies and Future Direction.脊柱和非脊柱骨转移 - 当前的争议和未来方向。
Clin Oncol (R Coll Radiol). 2020 Nov;32(11):728-744. doi: 10.1016/j.clon.2020.07.010. Epub 2020 Aug 1.
2
Prior therapies as prognostic factors of overall survival in metastatic castration-resistant prostate cancer patients treated with [Lu]Lu-PSMA-617. A WARMTH multicenter study (the 617 trial).对于接受[Lu]Lu-PSMA-617 治疗的转移性去势抵抗性前列腺癌患者，既往治疗作为总生存的预后因素。一项 WARMTH 多中心研究（617 试验）。
Eur J Nucl Med Mol Imaging. 2021 Jan;48(1):113-122. doi: 10.1007/s00259-020-04797-9. Epub 2020 May 8.
3
Clinical outcomes of 177lutetium-prostate-specific membrane antigen therapy in advanced prostate cancer-a prospective pilot study in an Asian population.177 镥前列腺特异性膜抗原治疗晚期前列腺癌的临床结果-亚洲人群的前瞻性初步研究。
Nucl Med Commun. 2020 Jul;41(7):618-628. doi: 10.1097/MNM.0000000000001179.
4
Bone Health in Men with Prostate Cancer: Review Article.前列腺癌男性的骨骼健康：综述文章。
Curr Osteoporos Rep. 2019 Dec;17(6):527-537. doi: 10.1007/s11914-019-00536-8.
5
A novel classification system for spinal instability in neoplastic disease: an evidence-based approach and expert consensus from the Spine Oncology Study Group.一种用于肿瘤性疾病脊柱失稳的新分类系统：基于证据的方法和脊柱肿瘤研究学会的专家共识。
Spine (Phila Pa 1976). 2010 Oct 15;35(22):E1221-9. doi: 10.1097/BRS.0b013e3181e16ae2.
6
Noninvasive Prediction of Fracture Risk in Patients with Metastatic Cancer to the Spine.转移性脊柱癌患者骨折风险的无创预测
Clin Cancer Res. 2009 Dec 15;15(24):7676-7683. doi: 10.1158/1078-0432.CCR-09-0420.
7
Critical evaluation of Mirels' rating system for impending pathologic fractures.对米雷尔斯（Mirels）即将发生病理性骨折的评级系统的批判性评估。
Clin Orthop Relat Res. 2003 Oct(415 Suppl):S201-7. doi: 10.1097/01.blo.0000093842.72468.73.
8
Metastatic disease in long bones. A proposed scoring system for diagnosing impending pathologic fractures.长骨转移性疾病。一种用于诊断即将发生的病理性骨折的拟议评分系统。
Clin Orthop Relat Res. 1989 Dec(249):256-64.

Is it necessary to do surgical fixation in metastatic bone disease impending pathologic fracture before Lu-prostate-specific membrane antigen radionuclide therapy?

作者信息

Assadi Majid

机构信息

Department of Molecular Imaging and Radionuclide Therapy, The Persian Gulf Nuclear Medicine Research Center, Bushehr Medical University Hospital, Bushehr University of Medical Sciences, Bushehr, Iran.

出版信息

World J Nucl Med. 2021 Sep 22;20(4):414-416. doi: 10.4103/wjnm.wjnm_147_20. eCollection 2021 Oct-Dec.

DOI:10.4103/wjnm.wjnm_147_20
PMID:35018166
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8686736/
Abstract
摘要